Neuroregeneration: pipelines, trials and challenges – an interview with the California Institute for Regenerative Medicine

Written by Lauren Pulling, Editor

As part of our Spotlight on neuroregeneration, we spoke to Helen Budworth, Kent Fitzgerald (both Science Officers) and Kevin McCormack (Senior Director Public Communications & Patient Advocate Outreach) from the California Institute for Regenerative Medicine (CIRM; CA, USA). They tell us more about CIRM’s current clinical portfolio and discovery pipeline, as well as the challenges involved in bringing neuroregenerative therapies to the clinic, and where we could be 10 years from now. First, please could you tell us about your backgrounds? How did you both become interested in regenerative medicine? HB: I completed my studies in the UK with a...

To view the full article, please register now for access

It's completely free